University of Dundee

Esther Sammler

New trial will investigate LRRK2 inhibitors for Parkinson’s

16 May 2023

A study that could lead to the development of new treatments for Parkinson’s disease has launched at the University of Dundee, Scotland. The study is utilising LRRK2 inhibitors developed by Denali Therapeutics and Biogen. Mutations in the LRRK2 protein kinase are the most frequent cause of inherited Parkinson’s disease and it is hoped that an […]